The COPII pathway and hematologic disease

R Khoriaty, MP Vasievich… - Blood, The Journal of the …, 2012 - ashpublications.org
R Khoriaty, MP Vasievich, D Ginsburg
Blood, The Journal of the American Society of Hematology, 2012ashpublications.org
Multiple diseases, hematologic and nonhematologic, result from defects in the early
secretory pathway. Congenital dyserythropoietic anemia type II (CDAII) and combined
deficiency of coagulation factors V and VIII (F5F8D) are the 2 known hematologic diseases
that result from defects in the endoplasmic reticulum (ER)–to–Golgi transport system. CDAII
is caused by mutations in the SEC23B gene, which encodes a core component of the coat
protein complex II (COPII). F5F8D results from mutations in either LMAN1 (lectin mannose …
Abstract
Multiple diseases, hematologic and nonhematologic, result from defects in the early secretory pathway. Congenital dyserythropoietic anemia type II (CDAII) and combined deficiency of coagulation factors V and VIII (F5F8D) are the 2 known hematologic diseases that result from defects in the endoplasmic reticulum (ER)–to–Golgi transport system. CDAII is caused by mutations in the SEC23B gene, which encodes a core component of the coat protein complex II (COPII). F5F8D results from mutations in either LMAN1 (lectin mannose-binding protein 1) or MCFD2 (multiple coagulation factor deficiency protein 2), which encode the ER cargo receptor complex LMAN1-MCFD2. These diseases and their molecular pathogenesis are the focus of this review.
ashpublications.org